Discuss the significance of India's indigenous H5N1 poultry vaccine for farm incomes and zoonotic risk. Should vaccination replace India's 'detect-and-cull' approach?
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
ICAR-NIHSAD, Bhopal, has developed India's first indigenous inactivated chicken vaccine against H5N1 HPAI Clade 2.3.2.1a. No commercial vaccine existed for this clade before [1]. The vaccine is a valuable new tool. It should be added to detect-and-cull, not used to replace it.
Significance for farm incomes
- HPAI kills nearly 100% of infected birds. India has had 500+ H5N1/H5N8 outbreaks since 2006 [1].
- The 2006 outbreak alone cost Rs 2,200–3,000 crore. A major outbreak could cut GDP growth by up to 1.5% through trade bans and price crashes [1].
- Fewer outbreaks mean less culling. They also lower the compensation bill for birds, eggs and feed under the Action Plan [2].
- Aatmanirbharta: India need not depend on imported vaccines during a crisis [1].
Significance for zoonotic risk
- The clade has spread to mammals and caused three human cases in India [1].
- WHO found Clade 2.3.2.1a in a child in Australia who had travelled to Kolkata. It noted that the clade circulates in South-East Asia [3].
- Vaccinating chickens lowers the viral load at its source. This fits the One Health approach.
Should vaccination replace detect-and-cull?
Limits of vaccination:
- Vaccinated birds can be infected without showing signs. Standard antibody tests may not tell vaccinated birds from infected ones.
- Trading partners may treat vaccinated flocks as suspect, which could prolong trade bans.
- The vaccine is clade-specific. Viral drift, or the arrival of Clade 2.3.4.4b, could weaken protection.
Limits of culling alone:
- Outbreaks have continued for two decades despite culling [1]. Each outbreak means paying compensation again [2].
Way forward: complement, not replace
- Targeted vaccination in high-risk zones and of breeding stock, with written DAHD guidelines.
- Surveillance and laboratory capacity, as the FAO-WOAH Global Strategy (2025) urges [4], plus genomic sequencing to update the vaccine strain.
- An exit plan that stops vaccination in a zone once outbreaks fall.
- Close coordination between MoA&FW (ICAR) and the Ministry of Fisheries, Animal Husbandry & Dairying.
The vaccine protects both farm incomes and public health. It works best as part of a layered strategy: test, cull where needed, and vaccinate selectively. Run this way, it serves SDG 2 and SDG 3 and makes India's One Health preparedness stronger.
Sources
- 1PIB Press Release: ICAR-NIHSAD Develops Indigenous H5N1 Vaccine to Strengthen Poultry Disease Control (Nov 2026)first indigenous inactivated vaccine for Clade 2.3.2.1a; no commercial vaccine for this clade; ~100% mortality; 500+ outbreaks since 2006; Rs 2,200–3,000 crore loss in 2006; up to 1.5% GDP impact; spread to mammals; three human cases in India
- 2PIB, Ministry of Fisheries, Animal Husbandry & Dairying: release on avian influenza and compensation under the Action Plan (Feb 2021)compensation for culled birds, eggs and feed; culling-based control
- 3WHO Disease Outbreak News: Avian Influenza A(H5N1) – Australia (2024-DON519)Clade 2.3.2.1a human case linked to travel to Kolkata; the clade circulates in South-East Asia
- 4FAO Newsroom: The spread of H5N1 highly pathogenic avian influenza calls for stepped up action, FAO saysFAO-WOAH 10-year Global Strategy; stronger surveillance, reporting and laboratory capacity
Practice
7 questions on this item
Check the answer for each question, or reveal all at once.